Sales rise 48.99% to Rs 178.13 crore
Net Loss of Orchid Pharma reported to Rs 6.59 crore in the quarter ended March 2022 as against net loss of Rs 24.73 crore during the previous quarter ended March 2021. Sales rose 48.99% to Rs 178.13 crore in the quarter ended March 2022 as against Rs 119.56 crore during the previous quarter ended March 2021.For the full year,net loss reported to Rs 1.95 crore in the year ended March 2022 as against net loss of Rs 116.53 crore during the previous year ended March 2021. Sales rose 24.33% to Rs 559.56 crore in the year ended March 2022 as against Rs 450.06 crore during the previous year ended March 2021.
ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales178.13119.56 49 559.56450.06 24 OPM %12.77-3.18 -8.876.33 - PBDT20.03-4.40 LP 85.07-7.61 LP PBT-6.59-24.73 73 -1.95-116.53 98 NP-6.59-24.73 73 -1.95-116.53 98
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
